DoP seeks MHA intervention for uninterrupted pharma ancillary Turkey

  • DoP seeks MHA intervention for uninterrupted pharma ancillary Turkey
  • DoP seeks MHA intervention for uninterrupted pharma ancillary Turkey
  • DoP seeks MHA intervention for uninterrupted pharma ancillary Turkey
  • Should Pharma organisations outsource ancillary supplies distribution?
  • Pharma organisations have elected to outsource requirements for ancillary supplies distribution (medical devices, laboratory equipment, patient supplies, etc.) to preferred partners that manage the chain via an integrated, end-to-end process.
  • Why are ancillary supplies important in clinical trials?
  • Ancillary supplies are a necessary component in every clinical trial, though these products are often perceived as secondary in importance to investigational medicinal products (IMPs).
  • What is Accenture's methodology for identifying Pharma interventions?
  • The methodology for identifying these interventions is interactive - through IPA‘s and CRISIL‘s facilitation, Accenture has conducted several interviews across large Indian pharma manufacturers, pharma ancillaries and industry SMEs to develop a holistic perspective.
  • Are ancillaries a challenge for IPA & Accenture?
  • These challenges are further compounded by the limited visibility industry stakeholders have into ancillaries. IPA and Accenture recognized that urgent action is required to support the ancillaries and therefore collaborated to identify interventions that will enable business recovery.

Recommended hot-selling products